A Review of Drug Prices of 2017

By: Fred Jankilevich Lawyer / Consultant – December 12th 2017 Prescription Drug spending is a major component of prescription drug spending in the United States. Prescription drug spending rose 12% in 2015 and another 6% in 2016. The present figure is $450 billion USD / yr. It constitutes approximately 20% Continue Reading

Tax Reform Update

By: Fred Jankilevich Lawyer / Consultant November 14th 2017   The tax-writing of The Senate began to disclose its tax-cutting proposal yesterday.   A recent interview with Steve Scalise over public media by Neil Cavuto on November 10th, reflects how immediacy is a central priority to the bill: “…in our Continue Reading

Impact of new iPhone Sales

By: Fred Jankilevich Lawyer – Consultant October 31st – 2017 The iPhone X has generated market controversy as Steve Jobb’s multibillion dollar empire struggles with an unhappy deal from Best Buy Co. The deal allows the latter company to charge $100 extra for a product that is already perceived by Continue Reading

Dow sets record-high close

McDermid B. NEW YORK – The Dow rose to a record high close while U.S. stocks kept their upward momentum Wednesday following Federal Reserve Chair Janet Yellen’s congressional testimony to gradually raise interest rates. Yellen’s speech was a nod to Wall Street as the Fed signalled it will gradually tighten Continue Reading